The authors reply.

[1]  H. Birn,et al.  Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications , 2019, BMC Nephrology.

[2]  V. Jha,et al.  Antibodies to M-type phospholipase receptor and immunological remission in treatment-resistant and relapsing membranous nephropathy. , 2018, Kidney International.

[3]  Nnamdi Kelechi Nwaohiri.  Studying the Effect of Vitamin D Supplementation on Vascular Function in CKD: A Work in Progress. , 2018, Journal of the American Society of Nephrology : JASN.

[4]  J. Wetzels,et al.  Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab. , 2018, Kidney international.

[5]  P. Kamphuisen,et al.  European guidelines on perioperative venous thromboembolism prophylaxis: Chronic treatments with antiplatelet agents. , 2017, European journal of anaesthesiology.

[6]  K. Moreau,et al.  Cholecalciferol, Calcitriol, and Vascular Function in CKD: A Randomized, Double-Blind Trial. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[7]  O. Djurdjev,et al.  Randomized Controlled Trial for the Effect of Vitamin D Supplementation on Vascular Stiffness in CKD. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[8]  J. Gris,et al.  Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications: A Randomized Controlled Trial , 2016, Obstetrics and gynecology.

[9]  S. Harwood,et al.  Ergocalciferol and Microcirculatory Function in Chronic Kidney Disease and Concomitant Vitamin D Deficiency: An Exploratory, Double Blind, Randomised Controlled Trial , 2014, PloS one.

[10]  J. Kaski,et al.  Impact of Vitamin D Supplementation on Arterial Vasomotion, Stiffness and Endothelial Biomarkers in Chronic Kidney Disease Patients , 2014, PloS one.

[11]  D. Singer,et al.  A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. , 2011, Journal of the American College of Cardiology.

[12]  D. Sherman.  Prevention of venous thromboembolism, recurrent stroke, and other vascular events after acute ischemic stroke: the role of low-molecular-weight heparin and antiplatelet therapy. , 2006, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[13]  B. Kasiske,et al.  KDIGO Clinical Practice Guideline for Glomerulonephritis , 2012 .